Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
15.12.25
/
50%
€170.00
Target price
15.12.26
€219.76
Performance (%)
-34.18%
Price
19.08.26
?
Summary
This prediction is currently active. Massive losses of -34.18% have been the result for the BUY prediction by The_Goldman_Sachs_Gr. This prediction currently runs until 15.12.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -3.410% | -3.410% |
| iShares Core DAX® | -0,87 % | 5,32 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % |
| iShares S&P 500 | -0,65 % | 2,07 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $225.00 to $258.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat